Israel Study: AI Diet Beats Mediterranean Diet for Prediabetes

A study from Israel is turning heads in the diabetes research world — and it could change the way American patients with prediabetes think about their diet. Scientists at the prestigious Weizmann Institute of Science in Rehovot used artificial intelligence and gut microbiome data to create personalized meal plans, then compared them head-to-head against the widely recommended Mediterranean diet. The results were striking.

What the Researchers Did

The Israeli team enrolled 225 adults with prediabetes — a condition affecting an estimated 96 million Americans — and randomly assigned them to one of two diets for six months, with an additional six months of follow-up. One group followed the well-known Mediterranean diet, rich in olive oil, vegetables, whole grains, and fish. The other group followed a Personalized Postprandial-Targeting (PPT) diet, where a machine learning algorithm analyzed each person's clinical data and gut bacteria to predict how their blood sugar would respond to specific foods — then built a diet around those predictions.

All participants wore continuous glucose monitors (CGM) and logged meals via a smartphone app throughout the study.

Key Findings (In US-Friendly Numbers)

Both diets helped lower blood sugar, but the AI-personalized diet did significantly better on two important measures:

• Time with glucose above 140 mg/dL: The Mediterranean diet group reduced their daily high-glucose time by about 18 minutes per day. The AI diet group reduced it by nearly 78 minutes per day — more than four times the improvement.
• HbA1c reduction: Mediterranean diet participants dropped their HbA1c by 0.08%, while the personalized diet group achieved a reduction of 0.16% — twice as much. Both groups started at an average HbA1c of 5.9%, squarely in the prediabetes range (5.7–6.4% by American Diabetes Association standards).

Importantly, these differences held up at the 12-month follow-up, suggesting lasting benefit — not just a short-term effect.

Why an Israeli Perspective Matters for US Patients

Israel has become a global leader in personalized nutrition science, partly because of groundbreaking microbiome research emerging from the Weizmann Institute itself. This study builds on years of Israeli research showing that two people can eat the exact same food and have completely different blood sugar responses. That insight is still underappreciated in standard US dietary guidelines, which tend to offer one-size-fits-all advice. Seeing these results replicated in a rigorous randomized clinical trial — published in Diabetes Care, the leading American diabetes journal — gives US clinicians and patients strong reason to pay attention.

Why This Matters for US Patients

The Mediterranean diet is currently one of the top dietary recommendations from the American Diabetes Association (ADA) for managing prediabetes and type 2 diabetes. This Israeli study doesn't discredit that advice — the Mediterranean diet did help participants. But it raises a compelling question: What if your diet was designed specifically for your body?

For the roughly 1 in 3 American adults with prediabetes, finding more effective blood sugar strategies is urgent. Without intervention, up to 70% of prediabetes cases progress to type 2 diabetes. A diet that cuts your daily time above 140 mg/dL by over an hour — and does it using your own gut microbiome data — could represent a meaningful step forward in personalized diabetes prevention.

CGM technology, once reserved for insulin-dependent patients, is also increasingly accessible to Americans with prediabetes. This study demonstrates how CGM combined with AI guidance could become a powerful prevention tool in everyday clinical practice.

The Bottom Line

A Mediterranean diet remains a solid, evidence-based choice. But this Israeli research suggests that personalized, AI-guided nutrition — tailored to your unique biology — may be the next frontier in prediabetes care. Ask your doctor whether personalized nutrition approaches or CGM monitoring might be right for you.

Source: Ben-Yacov O, Godneva A, Rein M, et al. Personalized Postprandial Glucose Response-Targeting Diet Versus Mediterranean Diet for Glycemic Control in Prediabetes. Diabetes Care. 2021;44(9):1980–1991. DOI: 10.2337/dc21-0162. PMID: 34301736.